When AI drafts queries, scores site readiness, flags safety issues, or generates document findings, Corevident clarifies who can rely on the output, what must escalate, what evidence is needed, and who remains accountable, so teams can move faster without approval ambiguity.
Examples of where AI may be used in clinical workflows
Corevident works inside your team through its AI-native operating environment to operationalize your AI use case with governance built into the deployment from the start. We turn governance into the working process, not a parallel document.
The outcome is a vendor-agnostic operational dossier that carries decision authority, accountability, evidence, approval, and oversight into your systems, vendors, and clinical operations processes.
If a pilot has already moved faster than the operating model around it, Corevident helps recover the governance foundation before scale.
Your governed AI deployment foundation includes:
Used to deliver Corevident engagements, not sold as a standalone platform.
Bring a real AI use case, workflow, vendor product, or pilot. Corevident works with your team to build governance into the deployment foundation, so decision authority, evidence, approval, and oversight carry into the way the work runs.
Corevident helps teams operationalize AI use in alignment with recognized expectations for quality, oversight, data integrity, traceability, and inspection readiness.
Translated into workflow-level requirements: authority, review, escalation, evidence, and oversight.
Corevident helps translate product capability into the decision-authority, evidence, escalation, and oversight language regulated buyers need before adoption.
For VendorsCorevident helps evaluate whether an AI-assisted workflow can be governed, inspected, and defended before it scales across teams, tools, vendors, or studies.
For Sponsors & CROsCorevident's approach reflects hands-on experience across life sciences operations, enterprise technology governance, automation, and regulated operating model transformation.
Corevident will help show what governed use would require before regulated exposure grows.